Top 50 Biotechnology Startup Investors in Oceania in December 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Oceania. We rank investors based on the number of investments they made in Biotechnology companies from Oceania. We update this investor list every month.Top 50 Biotechnology Startup Investors in Oceania in December 2024
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Diraq — Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there.
- Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro Shatters the Wi-Fi HaLow Range Record... AgainSets New Benchmark in Connectivity with Record 16 km Wi-Fi HaLow Range Watch Now Smarter,
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Funding Round, Series A
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
- Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- New Zealand, United States, United Kingdom
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Watchful — Watchful operates as an AI security company.
- Crimson Education — Crimson Education is the world's leading higher educational consultancy helping students around the world gain admission into leading US and UK universities by up to 400%!
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Series B
- Australia, United States, Philippines
Portfolio highlights
- Q-CTRL — Infrastructure software to power the quantum future
- Samsara Eco — Samsara Eco is an enviro-tech company creating infinite recycling to end plastic pollution.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Debt Financing, Funding Round
- Australia, United States, Israel
Portfolio highlights
- Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
- StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
- Employment Hero — Employment Hero is Australia's top cloud-based HR, payroll and benefits platform for employers & employees. FREE trial for...
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
- Biotechnology, Information Technology, Manufacturing
- Angel, Seed, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Aurtra — Aurtra delivers highly cost-effective asset management solutions for power distribution transformers through online condition monitoring and state of the art analysis.They provide the insight to significantly reduce capital costs through maximum asset utilisation. Aurtra is an Australian company, based in sunny Brisbane, Australia. Aurtra wasincorporated in 2016 and has built its IP upon a foundation of world’s best practice technology from The University of Queensland, following a decade of transformer research between academia and industry. Aurtra’s three founders, all with success commercialising hardware and software technology, recognised the potential of the technology and its beneficial impact for asset management in the power distribution industry.
- Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
- Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Hong Kong
Portfolio highlights
- Bygen — Bygen delivers high-quality activated carbon products while also facilitating large-scale, long-term carbon dioxide sequestration.
- Ohmie Go — EV charging solutions, shared electric vehicles, shared e-bikes & e-scooters delivered to residents as a premium managed service and amenity - An intelligent way to get EV ready with one seamless experience.
- Sova Health — Sova Health is a precision nutrition platform that guides users towards a healthier lifestyle with personalized nutrition advice based on accurate blood biomarker analysis. Understand what is stopping you from achieving your nutritional goal and get your personalized nutrition plan.
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Seed, Angel
- New Zealand, United States, United Kingdom
Portfolio highlights
- Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
- Yabble — Yabble provides a platform that uses machine learning and natural language processing to help brands connect with more than 62 million consumers globally, and collect data in real-time. Using the solution, clients can build their own surveys and manage their own customer research communities.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Finistere Ventures is an agricultural technology and life sciences venture capital investor. Founded in 2005, the company partners with other entrepreneurs and creative thinkers to build innovative companies that have the potential to transform modern agriculture, increase food security, improve nutrition, and enhance sustainability. Their appliedexperience as operators, and pioneering role in Ag Tech, is actively utilized to benefit its portfolio companies and Partners. Finistere has global access to the best new technologies from centers of Ag Tech excellence in the U.S., Australia, Israel, New Zealand, and Canada through its venture partner networks. Finistere’s locations in San Diego and Palo Alto, California keeps them connected to the centers of mainstream venture investment and the world’s leading innovation ecosystem.
Show more
Investment focus
- Biotechnology, Agriculture, Farming
- Series B, Series C, Series A
- United States, New Zealand, Israel
Portfolio highlights
- Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
- Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Your guide to finding and using government services.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Seed, Series A, Angel
- New Zealand, United States, Japan
Portfolio highlights
- Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
- Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Series A, Funding Round
- New Zealand, United States
Portfolio highlights
- Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
- Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Software
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
- Medal — Gamers live here. Medal is the best way to record, clip, edit, and share your gaming clips and videos. Clip, Edit, Share, and Relive your gaming moments.
- ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more
Investment focus
- Information Technology, Software, Artificial Intelligence
- Seed, Angel, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- ReciMe — ReciMe is the ultimate cooking app that helps you save, share, and discover new recipes. It was founded in 2020 and is located in Melbourne, Victoria, Australia.
- PropCode — PropCode is a online platform, that helps in researching for town planning queries. the rules can be complex, and make it easy to get the right answers.
- Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
Founded in 1996, GBS invests in young businesses developing and commercialising products which, when combined with the right management and finance, will make a significant difference to patients' lives and deliver financial returns for their investors. Their areas of particular interest and expertise include human healthcare, biotechnologyproduct development and life science start-ups. In particular, recent investments have included biological or small molecule therapeutics, medical devices and diagnostics.GBS invests in private or public companies whether at start-up or later stages of company development. Their investors include major Australian superannuation funds.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Australia, United Kingdom
Portfolio highlights
- Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
- Elastagen — Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen hasdeveloped a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.
- AirXpanders — AirXpanders develop technology enabling tissue expansion after reconstructive surgery with an emphasis on breast reconstruction. It addresses current unmet needs for patients who require tissue expansion after reconstructive surgery with the first emphasis on breast reconstruction. Present methods of tissue expansion utilize saline-filled implantsthat are typically injected on a weekly basis after surgery in order to reach the volume of skin and tissue required for the placement of a permanent breast implant.
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A
- Australia
Portfolio highlights
- Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
- Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more
Investment focus
- Biotechnology, Robotics, Nanotechnology
- Seed
- New Zealand, United States
Portfolio highlights
- Ligar — Providing molecular filtration solutions to companies in the food, beverage, health, therapeutics, flavour and aroma industries. Our unique MIP and Polymer technology enables companies to improve their products and operational processes by extracting, reducing or concentrating flavours or compounds.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- PowerON — Dielectric Elastomers for Soft Robotics
Access exclusive venture capital angel investment deals in pre-vetted startup companies. Create your free OurCrowd investor account today!
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series B, Series A, Seed
- Israel, United States, New Zealand
Portfolio highlights
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- Kando — Kando is an end-to-end solution that creates continuous awareness of events in the collection system. Kando enables utilities to remotely and continuously improve their operations by providing the following features:• Realtime wastewater quality data across the collection system • Pinpoint sources of pollution • Early warnings of damaging WWTPinfluent quality • Machine learning that evolves with your network • Autonomous sampling units • User fee calculator • Customized pollution alerts • A user-friendly, online interface • Detection of COVID-19 infection rates (New)The combination of these actionable insights results in:• Reduced CAPEX/OPEX • Greater WW reuse capabilities • Improved public health • Cleaner environmentsKando has been deployed in Los Angeles, Milan, Brisbane, and many other cities. To gain a greater understanding of how our system can help your organization, visit our homepage at www.kando.eco.
- Blue Tree Technologies Ltd. — Blue Tree’s mission is to develop a sugar reduction platform for industrial applications in the drinks industry.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
- Software, Enterprise Software, Information Technology
- Series A, Series B, Funding Round
- United States, Australia, Philippines
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,251,604 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
The Clean Energy Finance Corporation invests using a commercial approach to overcome market barriers and mobilize investment in renewable energy, energy efficiency, and low emissions technologies. They seek to catalyze and leverage private sector funding for the commercialization and deployment of clean energy technologies necessary for thetransition to a carbon-constrained economy.
Show more
Investment focus
- Energy, Renewable Energy, Real Estate
- Debt Financing, Series B, Seed
- Australia, United States, Spain
Portfolio highlights
- Plenti — When it comes to money, every decision counts. From what you borrow, and when you pay it back. To where you invest it, and how you make it go further. We’re on a mission to help everyone to make the right choices — about the choices that count.
- Team Global Express — Send parcels to family and friends anywhere with Team Global Express offering the BEST and fastest freight, parcel delivery service. Trusted Partner, world class eCommerce Leader in digitally connecting customers globally
- Downforce Technologies — Downforce Technologies is a pioneering leader in science-led, data-driven land management solutions focused on optimising soil health, soil organic carbon levels and biodiversity. With over 30% of the world's soil already degraded, urgent action is needed to address this pressing global challenge. Our platform offers a complete,high-resolution view of the land's carbon profile, enabling precise analysis and site-specific strategies for optimizing carbon levels.
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.
Show more
Investment focus
- Biotechnology, Analytics, Health Care
- Series A, Seed, Series B
- Australia
Portfolio highlights
- Nexgen Plants — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
- Icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
- Agworld — Agworld Farm Management software allows you to collect data at all levels and enables you to extract maximum value from this data; optimising profitability. The Agworld ecosystem is utilised by growers, agronomists and service providers on farms across the world.
Rabobank emerged from several small agricultural cooperative banks, founded by Dutch farmers in the late nineteenth century. Food & Agriculture (F&A) is in our DNA, from which we built a unique position in the F&A sector as a key financier and international player, attributes which we leverage for the benefit of our stakeholders andportfolio companies. We recognise and understand the food security challenges lying ahead of us and how Innovation in F&A supply chains is key to the solution, which is why we are dedicated to committing capital to the space.
Show more
Investment focus
- Agriculture, AgTech, Farming
- Series A, Series B, Seed
- United States, The Netherlands, Canada
Portfolio highlights
- 30MHz — The data platform for horticulture | Sense. Act. Impact.
- MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
- EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
Queensland Investment Corporation is an investment company.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Seed, Series A, Funding Round
- Australia, United States
Portfolio highlights
- Gelomics — Gelomics operates as a biotechnology company. Gelomics provides 3D cell culture technologies.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Renewa — Renewa is a top renewable energy land & infrastructure investor that buys land, ground leases, & royalties to help landowners attain financial security.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Pre-Seed, Series A
- Germany, Australia, United States
Portfolio highlights
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
- HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
- Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
- Software, Apps, Information Technology
- Seed, Series A, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
- HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
- SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
From idea to impact.
Show more
Investment focus
- Medical, Biotechnology
- Series B
- United Kingdom
Portfolio highlights
- PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
- Vicebio — Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses. Vicebio is a biopharmaceutical business that creates innovative vaccinations to prevent potentially fatal respiratory viral infections.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
- Health Care, Biotechnology, Therapeutics
- Seed, Series A, Series B
- United Kingdom, United States, Australia
Portfolio highlights
- Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
- Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
- MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Callaghan Innovation is a stand-alone Crown Entity established on 1 February, 2013. Their role hasn’t previously existed in New Zealand.When they succeed, all New Zealanders will benefit from a stronger economy, higher value exports, more productive and sustainable resource use, more jobs and higher incomes.International evidence showsadvanced technology institutes like Callaghan Innovation have been successful at helping businesses build innovation capability that contributes to their growth and the broader economy.
Show more
Investment focus
- AgTech, Construction, Horticulture
- Seed, Pre-Seed, Funding Round
- New Zealand
Portfolio highlights
- Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
- DNAiTECH — At DNAiTECH we develop innovative portable isothermal amplification instruments for point of care diagnostics, in-field applications, and rapid DNA testing.
- Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more
Investment focus
- Software, Financial Services, Health Care
- Seed, Series B, Funding Round
- Australia, Germany
Portfolio highlights
- Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
- Sprout Stack —
- Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.
Show more
Investment focus
- Software, E-Commerce, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Singapore
Portfolio highlights
- Decarice — Explore DeCarice's hydrogen retrofit technology to significantly reduce carbon emissions from your existing diesel fleet. Decarbonize with innovative solutions for a sustainable future.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- FiberSense — FiberSense is providing cities and critical infrastructure operators with game changing real-time detection of objects and events.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
- FinTech, Financial Services, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, Hong Kong, Singapore
Portfolio highlights
- Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
The George Institute for Global Health is an independent medical research institute that helps to improve the health of millions of people worldwide. With projects in more than 50 countries, it has raised over 500 million dollars for global health research since 1999, and it has been ranked among the top 10 research institutions in the world forscientific impact by the SCImago Institution Rankings World Report in 2011, 2012, 2013, and 2014.The George Institute for Global Health’s work includes preventing heart disease in India, improving healthcare for Aboriginal and Torres Strait Islander Australians, closing healthcare gaps in China, making roads safer around the world, preventing the complications of diabetes, changing decades old thinking about intensive care, improving outcomes among stroke survivors, using mobile technology to make healthcare accessible worldwide, and developing tools to empower people to improve their own health.The George Institute for Global Health was founded in 1999 and is based in Sydney.
Show more
Investment focus
- Biometrics, Health Care, Biotechnology
- Seed
- Australia
Portfolio highlights
- CellSync — CellSync : shaping the future of cell engineering.
- Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Tenacious Ventures - Australia's first and only dedicated agrifood tech VC firm.
Show more
Investment focus
- Agriculture, AgTech, Software
- Seed, Pre-Seed, Series A
- Australia, United States
Portfolio highlights
- Azaneo — Azaneo develops lightning-fast electric weeding technology. Using only electrons - herbicide free.
- Goterra — Goterra's modular waste management systems use insects to process food and organic waste, converting it to sustainable protein and fertiliser
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more
Investment focus
- Software, Biotechnology, Financial Services
- Series A, Series B, Series C
- Australia, United Kingdom, United States
Portfolio highlights
- Hysata — Hysata is a developer of hydrogen electrolyzer designed to accelerate the world's shift away from fossil fuels to green hydrogen
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- SafetyCulture — SafetyCulture is the operational heartbeat of working teams around the world. Its mobile-first operations platform leverages the power of human observation to identify issues and opportunities for businesses to improve everyday. More than 28,000 organisations use its flagship products, iAuditor and EdApp, to perform checks, train staff, reportissues, automate tasks and communicate fluidly. SafetyCulture powers over 600 million checks per year, approximately 50,000 lessons per day and millions of corrective actions, giving leaders visibility and workers a voice, in driving safety, quality and efficiency improvements.
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Funding Round, Series A, Seed
- Australia, United States, The Netherlands
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
We Invest in the Circular Economy, a New Economic Model Focused on a Profitable and Sustainable Future.
Show more
Investment focus
- Recycling, Supply Chain Management, Artificial Intelligence
- Series A, Seed, Funding Round
- United States, United Kingdom, Chile
Portfolio highlights
- MOLG — MOLG develops and provides digital and automation tools to manage services and processes of businesses from the manufacturing industry. It is based in Virginia, USA.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Neutreeno — Neutreeno is a deep tech spinout from the University of Cambridge that engineers an intelligent decarbonization system.
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more
Investment focus
- Biotechnology, Renewable Energy, Energy
- Seed, Series A, Series B
- United States, United Kingdom, France
Portfolio highlights
- Acceleron Fusion — Acceleron Fusion provides clean energy solutions by using fusion technology.
- Matter Intelligence — Matter Intelligence is creating the most detailed map of the world using first-of-a-kind sensors to understand our planet like never before
- Ulysses Ecosystem Engineering — Ulysses rewild the ocean and remove gigatons of carbon, contributing to global efforts to combat climate change and restore marine ecosystems.
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series B, Series C, Funding Round
- United States, India, Austria
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Backing a better tomorrow
Show more
Investment focus
- Renewable Energy, Software, Biotechnology
- Series A, Series B, Seed
- Australia, United States, Hong Kong
Portfolio highlights
- Gridmo — gridmo accelerates the connection of generation to the grid. Unlock access to fast and accurate power system studies.
- Lydian — Lydian aims to accelerate the decarbonization of the chemical industry by electrifying the chemical production process. Founded in 2021 by Branko Zugic, Lydian is headquartered in
- Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more
Investment focus
- Events, Sports, Cycling
- Pre-Seed
- Hong Kong
Portfolio highlights
- Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
- VueMotion Labs — Optimize athletic performance with VueMotion's AI-driven movement analysis. Accessible, affordable, and trusted by pro teams worldwide. Start testing today!
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
- Software, SaaS, Apps
- Seed, Funding Round, Angel
- Australia, United States
Portfolio highlights
- Trendspek — Make confident decisions on high-value infrastructure with speed, safety, and precision. Use Trendspek's intuitive 3D environment to interactively report asset conditions, streamline the O&M phase with advanced workflow tools, and securely share insights with global teams for informed decision-making. Empowering teams in 20+ countries.
- Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Mike Wallas - Advisory Board @ Optifire Pty Ltd
Show more
Investment focus
- Video, Water, Biotechnology
- Seed, Funding Round
- Australia
Portfolio highlights
- PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
- Clipchamp — Clipchamp is the online video editor that empowers anyone to tell stories worth sharing. Our in-browser platform gives users access to professional video editing tools and features from simple cropping and resizing to special effects like transitions, motion titles, and even Green Screen. Also on offer – an 800 thousand asset strong stock libraryand hundreds of editable video templates.
Empath Ventures is a venture capital firm that mainly invests in psychedelic medicine companies. The firm specializes in the fields of investment financial services, finance, and venture capital.
It was founded in 2021 and headquartered in Los Angeles California.
Show more
Investment focus
- Health Care, Biotechnology, Personal Health
- Seed, Pre-Seed, Convertible Note
- United States, United Kingdom, Canada
Portfolio highlights
- Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Motif Neurotech — We're building DOT, a miniature brain stimulator designed to restore healthy brain activity in patients with treatment-resistant depression.
- Aperture Therapeutics — Aperture Therapeutics is building an innovative drug discovery platform that embraces the genetic diversity of patients and leverages mechanistic understanding of protective gene variants in the human population.
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more
Investment focus
- Medical, Health Care, Therapeutics
- Pre-Seed
- Australia
Portfolio highlights
- Cell Bauhaus — Cell Bauhaus uses mathematical and computer modeling to understand, predict, and modify living cell behavior, aiming to expedite sustainable solutions to humanity's pressing issues.
- Remagine Labs — Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world.
- Psychae Therapeutics — Psychae Therapeutics is a biotechnology company creating transformative psychedelic-assisted therapies that combine the best of nature with modern pharmaceutical science. Our vision is to integrate the profound healing properties of botanical psychedelic substances with rigorous evidence-based medi
We're a global dairy nutrition company owned by 10,000 farmers and their families, united by a fundamental belief in the power of dairy to make a difference.
Show more
Investment focus
- Food and Beverage, Nutrition, Dietary Supplements
- Seed, Series B, Funding Round
- Germany, New Zealand, United States
Portfolio highlights
- Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
- Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
- Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more
Investment focus
- Software, Health Care, Machine Learning
- Seed, Funding Round, Series A
- United States, Colombia, India
Portfolio highlights
- Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
- Natilus — Natilus is a large scale drone manufacturing company. The company specializes in the manufacturing of Boeing 747 sized drones which provides inter-continental cargo delivery services and helps in reducing air freight costs. Natilus was founded by LZ Zhang, Anatoly Starikov and Aleksey Matyushev in 2016.First flight of their 2200 lbs / 30 ftdrone is scheduled for Summer 2018. At the end of 2018, Natilus completed a flight test of their 2200 lbs prototype.The first production vehicle scheduled for 2020 customer delivery underwent wind tunnel testing in April, 2019. Natilus currently holds an aircraft order book rumored to be in excess of $1B+.
- Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Ellerston Capital is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Funding Round, Seed, Series A
- Australia, Hong Kong, United Kingdom
Portfolio highlights
- Willed — Willed is an Australian online estate planning platform.
- BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
- Internet 2.0 — Military Grade cyber security with core products Cloaking Firewall, Malcore and 5th Column
Investors by industry
Biotech
Proptech
Gaming
FinTech
Health Care
Community
Google
Marketplace
Climate
Consumer
Artificial intelligence
Impact
Energy
Hardware
EdTech
Sustainability
Venture Capital
Clean Energy
B2B
Real Estate
Publishing
Payments
Big Data
Retail
Organic Food
Web3
Education
Finance
Food and Beverage
Video Games
Infrastructure
Financial Services
Photography
Beauty
Medical
Wellness
Social Media
Social Network
Android
Construction
Art
Local
Legal
Digital Media
Manufacturing
eSports
Sports
Music
Mobile
Internet
Enterprise Software
Franchise
Email
Travel
Mobile Advertising
Biotechnology
Recruiting
Hospitality
Fitness
Platforms
Cannabis
Medical Device
Social
Automotive
Crowdfunding
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Social Impact
Restaurants
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Canada
New Zealand
Ireland
United States
Qatar
Saudi Arabia
Spain
Sri Lanka
China
Middle East
Africa
Indonesia
Europe
Armenia
Singapore
Oceania
Brazil
Japan
South Africa
Vietnam
LATAM
Asia
Denmark
Costa Rica
Bermuda
Egypt
Croatia
Gibraltar
Algeria
Estonia
Ecuador
Greece
Chile
Bulgaria
Ethiopia
Hong Kong
Lebanon
Mali
Liberia
Malta
Liechtenstein
Malaysia
Italy
Panama
Myanmar
Mauritius
Nicaragua
Philippines
Lithuania
Israel
Jersey
Norway
Morocco
Mexico
Peru
Kuwait
Puerto Rico
Tunisia
Uganda
Sierra Leone
Senegal
San Marino
Uzbekistan
Seychelles
Togo
El Salvador
Rwanda
Russian Federation
Tanzania
Ukraine
Zimbabwe
Uruguay
Serbia
Taiwan
Venezuela
Tajikistan
Sweden
Turkey
Poland
Thailand
Zambia
Portugal
Slovenia
Dominican Republic
Azerbaijan
Iraq
Iceland
Bahamas
Namibia
Nigeria
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Faroe Islands
France
Ghana
Czech Republic
Bangladesh
Argentina
Grenada
Jordan
Romania
Hungary
Georgia
Belgium
Finland
Bahrain
Belarus
Belize
Barbados
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Colombia
Marshall Islands
Guatemala
Investors in Oceania by industry
Restaurants
Crowdfunding
Retail
Social
Cryptocurrency
Finance
Real Estate
Food and Beverage
Video Games
Medical
Organic Food
Wine And Spirits
Wellness
Medical Device
Non Profit
Email
Enterprise
Internet
Social Media
Social Network
Art
Manufacturing
Music
Digital Media
Android
Mobile
Legal
Construction
Local
Software
Financial Services
eSports
Enterprise Software
Sports
Fitness
Hospitality
Automotive
CleanTech
Travel
Platforms
Biotechnology
FinTech
Cannabis
Consumer
Health Care
Biotech
EdTech
Energy
Climate
Sustainability
Impact
Proptech
Marketplace
SaaS
Community
Hardware
Beauty
B2B
Fashion
Web3
Life Science
Big Data
Blockchain
Publishing
Sporting Goods
Education
Clean Energy
Oil and Gas
Renewable Energy
Social Impact
Infrastructure
Mobile Apps
Artificial intelligence
Transportation
Venture Capital
Agriculture (agtech)
Facebook
Media (entertainment)
InsurTech
Recruiting
Gaming
Payments